Developing the tools to drive the 3D-Bioprinting Revolution
In the past 5-6 years breakthroughs in design, form factor, foot print and cost have made 3D-bioprinters more affordable and accessible to the academic research environment. The future of 3D-Bioprinting hinges on the ability to translate lab-scale research and successes to clinically viable solutions. solutions. While hardware development has surged ahead, the development of materials to print "THE BIONK" has lagged behind. Like the development of high quality color inks at affordable prices drove the color printer revolution, we aim to drive the 3D-Bioprinting revolution through innovations in BIOINKS.
Our goal is to develop high performance BIOINKS that have HI-FIDELITY in their performance characteristics, are BIOCOMPATIBLE, are AFFORDABLE, widely AVAILABLE, is compatible with the merging 3D-Bioprinting hardware landscape and more importantly can be TRANSLATED in to the CLINIC.
OUR BIOINK PLATFORM (link1, link2)
Our patented carboxylated Agarose (CA) family of polymers have an unique property profile
Want to know more about CA-BIOINKS? click here Check out this highly timely article on 3DP in Pharma click here
If you are interested in our BIONK PLATFORM or would like to COLLABORATE with us please contact us.
Email
Our goal is to develop high performance BIOINKS that have HI-FIDELITY in their performance characteristics, are BIOCOMPATIBLE, are AFFORDABLE, widely AVAILABLE, is compatible with the merging 3D-Bioprinting hardware landscape and more importantly can be TRANSLATED in to the CLINIC.
OUR BIOINK PLATFORM (link1, link2)
Our patented carboxylated Agarose (CA) family of polymers have an unique property profile
Want to know more about CA-BIOINKS? click here Check out this highly timely article on 3DP in Pharma click here
If you are interested in our BIONK PLATFORM or would like to COLLABORATE with us please contact us.
